Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
IgA nephropathy (IgAN) is the most frequent primary glomerulonephritis worldwide. Due to its heterogenicity, there is a need to establish robust biomarkers for IgAN, to support treatment decisions and evaluate the risk of progression to end-stage renal disease. Using both clinical and histopathologi...
Main Authors: | Andrzej Konieczny, Piotr Donizy, Tomasz Gołębiowski, Andrzej Tukiendorf, Agnieszka Hałoń, Mariusz Kusztal, Hanna Augustyniak-Bartosik, Magdalena Krajewska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/10/1764 |
Similar Items
-
Crescents and IgA Nephropathy: A Delicate Marriage
by: Hernán Trimarchi, et al.
Published: (2022-06-01) -
Machine Learning in Prediction of IgA Nephropathy Outcome: A Comparative Approach
by: Andrzej Konieczny, et al.
Published: (2021-04-01) -
Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
by: Byeong Yun Yang, et al.
Published: (2012-09-01) -
Secondary Publication: Clinical Grade of IgA Nephropathy
by: Takahito Moriyama, et al.
Published: (2020-03-01) -
Management of IgA Nephropathy in Pediatric Patients
by: Sophie Schroda, et al.
Published: (2022-05-01)